The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Whoops, apols for the typo.
Krill.
For a better understanding, I suggest you read Laguito’s response at 13:26 on the 20th April to my post.
TRACTION!
MOMENTUM!
It's beginning to grip the wheels as new markets launch.
There is more stuff they are working on, for example: They are looking at developing a female version of eroxon! Aparently it can make the clitarus arowsed/erect.
The Dr Rena Malik endorsement clip is almost 5 Million ...one of her highest
Simple as that
The clip of the guy in the US showcasing Eroxon has over a million views. Check it out if you don’t believe me. Amplify that for all the markets the product is now launched into, or will be soon.
This will be a social media phenomenon once it is fully launched worldwide. Gotta love algorithms!
Some new Eroxon clips In Hindi /Latin America Spanish etc with some high views ..
Correction
Haleon reported that Eroxon would be launched by 2025
That means it is well within the next few months
Ilovesushi, If My memory serves me right they said at the presentation that launch in 2025 . What has changed since on USA front?
Up 8.5%
What a nice start. I am expecting good news from the USA and an update on distribution there. That is where the money will be made. Any day now.
Moving up now.
You could be right…. If they are planning for a buyout as the end game then slow mass accumulation would be very advantageous to them…… I expect a lot of people would in fact do the same…. Self preservation for the future
Clearly JB doesn't want the share price to go too yet just yet as he is accumulating ridiculous number of options at a very low price. Once he has about 10-15million he will probably start producing more positive news feeds. Never met a board that aren't kmly jn.it for themselves!
I have previously questioned whether the BoD had a cunning plan, for not being proactive in reacting to positive news. I have now concluded that the BoD are in infect, acutely inapt.
They appear to be happy to doddle along drawing on their current remuneration.
That it takes a PI to share the latest positive news and stop the share price slide.
SHAME on you JB.
If only there was a mechanism to remove him.He has always been way out of his depth.
Don’t get me started on the CFO.
All credit for Finnish news must go to milktrayman, I only copied and pasted it to Investor relations
Indeed nice one Busters, the BOD needs their heads knocking together. I wasn't aware of the launch in Norway and to then be a top seller in only two weeks surely this is newsworthy?
I think the tree shake will now see a very poweful rally
Nice one busters, salute you sir. Pls keep us updated with how it goes, I too will be looking forward to their response.
Although the CEO stated the company has no control over the share price, it can issue news items which helps sentiment and supports the share price.
Why doesn't the company issue Reach RNS's when positive news is announced by its distributors such as the recent one for Norway......
“The successful launch in Norway of Eroxon® in February was an important and significant event. After only two weeks in the market, this clinically proven local treatment of erectile dysfunction was the bestseller at an online pharmacy. Strong sales in the rest of the first quarter, resulted in Eroxon® ranking third on Navamedic’s most sold products in the Consumer Health segment. Eroxon® will be launched in Sweden in May, and in Finland later this year,” said Kathrine Gamborg, CEO of Navamedic ASA.
https://news.cision.com/navamedic-asa/r/navamedic-q1-2024--successful-product-launch-and-steady-operational-progress,c3970410
Snippets of news like this would go a long way to underpin the share price rather than allow the constant drip, drip downwards. Private investors cannot allow their savings to reduce day after day so consequently have to limit their losses by selling where as Institutional investors hold for the long term. What is the company doing to attract more Institutional investors ?
Hoping you will pass this on to the board, I look forward to hearing their response
Sent to Investor relations today.
FYI :
“The successful launch in Norway of Eroxon® in February was an important and significant event. After only two weeks in the market, this clinically proven local treatment of erectile dysfunction was the bestseller at an online pharmacy. Strong sales in the rest of the first quarter, resulted in Eroxon® ranking third on Navamedic’s most sold products in the Consumer Health segment. Eroxon® will be launched in Sweden in May, and in Finland later this year,” said Kathrine Gamborg, CEO of Navamedic ASA.
https://news.cision.com/navamedic-asa/r/navamedic-q1-2024--successful-product-launch-and-steady-operational-progress,c3970410
I personally can’t see the point in the company anymore as it only exists for Eroxon! Haleon are doing everything their end from manufacture to distribution, coopers only distribution with 3rd party manufacture. Once the outstanding deals are completed then the BoD are redundant in my eyes, not much to develop & expand the range with really.